Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.54
-0.17 (-1.45%)
May 5, 2026, 12:44 PM EDT - Market open
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $228.35 million as of May 5, 2026. Its market cap has decreased by -59.99% in one year.
Market Cap
228.35M
Enterprise Value
-38.82M
1-Year Change
-59.99%
Ranking
Category
Stock Price
$11.54
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $228.35M, a decrease of -40.74%. That is a compound annual growth rate of -8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 231.72M | -62.64% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaryx Therapeutics | 242.40M |
| Adagene | 241.83M |
| Nuvectis Pharma | 235.51M |
| Orchestra BioMed Holdings | 235.25M |
| Achieve Life Sciences | 233.72M |
| Milestone Pharmaceuticals | 232.42M |
| Voyager Therapeutics | 231.25M |
| Heron Therapeutics | 230.14M |